Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect

scientific article published on 25 October 2018

Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJRESP-2018-000339
P932PMC publication ID6203022
P698PubMed publication ID30397486

P50authorMatthew SperrinQ50893533
Alexander PateQ90730969
Michael Andrew BarrowmanQ92317848
P2093author name stringRachael Williams
Kourtney J Davis
David Webb
Tjeerd Van Staa
Jeanne M Pimenta
P2860cites workMethods for evaluating changes in health care policy: the difference-in-differences approachQ41711592
A Tutorial on Multilevel Survival Analysis: Methods, Models and ApplicationsQ47094118
Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.Q47607188
Transportability of Trial Results Using Inverse Odds of Sampling Weights.Q47834798
Understanding the Hawthorne effect.Q50794924
How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?Q81323651
Generalized Poisson distribution: the property of mixture of Poisson and comparison with negative binomial distributionQ82154625
The Hawthorne effect: stronger than the placebo effect?Q84530783
Pragmatic trials: how to adjust for the 'Hawthorne effect'?Q84818549
The Hawthorne Effect: a randomised, controlled trialQ21261930
Data Resource Profile: Clinical Practice Research Datalink (CPRD)Q28645951
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataQ30955660
Adaptation and validation of the Charlson Index for Read/OXMIS coded databasesQ33522043
Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countriesQ33823425
Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trialQ34041659
Obtaining real-world evidence: the Salford Lung Study.Q34608276
What Happened at Hawthorne?: New evidence suggests the Hawthorne effect resulted from operant reinforcement contingenciesQ34672356
The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trialsQ35204750
Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare RecordsQ35951223
External validity of randomised controlled trials: "to whom do the results of this trial apply?".Q36003704
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effectsQ37671448
Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using "Real-World" DataQ38675569
Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trialQ38689738
Streamlining cardiovascular clinical trials to improve efficiency and generalisabilityQ38813577
Real-World Evidence - What Is It and What Can It Tell Us?Q40427436
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectchronic obstructive pulmonary diseaseQ199804
P304page(s)e000339
P577publication date2018-10-25
P1433published inBMJ open respiratory researchQ27725957
P1476titleStudy investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect
P478volume5

Reverse relations

cites work (P2860)
Q92442128Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data
Q92578404Real-World Data and Randomised Controlled Trials: The Salford Lung Study

Search more.